AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglib GM 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Mas Life Science

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglib GM 2mg/500mg/0.3mg Tablet

Diabetisyn 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabetisyn should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Regular meals and readily available fast-acting glucose sources (sugary foods or juice) are essential. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your doctor prior to initiating treatment. Pregnant or breastfeeding women should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Uses of Voglib GM 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Voglib GM 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Voglib GM 2mg/500mg/0.3mg tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.

Common Side effects of Voglib GM 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglib GM 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Voglib GM 2mg/500mg/0.3mg Tablets should be administered on an empty stomach.

How Voglib GM 2mg/500mg/0.3mg Tablet works:

Each Voglib GM tablet (2mg/500mg/0.3mg) contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Voglib GM 2mg/500mg/0.3mg Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Voglib GM 2mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Voglib GM 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Voglib GM 2mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be avoided. Patients with severe kidney disease should not use this medication. Medical advice is recommended.

LiverLiverCAUTION

Exercise caution when administering Voglib GM 2mg/500mg/0.3mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Voglib GM 2mg/500mg/0.3mg tablet therapy with a reduced starting dose; its use is contraindicated in those with severe liver disease.

What if you forget to take Voglib GM 2mg/500mg/0.3mg Tablet :

Should you forget a Voglib GM 2mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglib GM 2mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglib GM 2mg/500mg/0.3mg Tablet

Voglib GM 2mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This treatment improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Voglib GM 2mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Voglib GM 2mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any ingredient. This medication should also be avoided in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Voglib GM 2mg/500mg/0.3mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglib GM 2mg/500mg/0.3mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Voglib GM 2mg/500mg/0.3mg...
101
MRP 123
17% off